Bleeding
324
30
40
167
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Published Results
31 trials with published results (10%)
Research Maturity
167 completed trials (52% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
7.1%
23 terminated out of 324 trials
87.9%
+1.4% vs benchmark
26%
84 trials in Phase 3/4
19%
31 of 167 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 167 completed trials
Clinical Trials (324)
Quantra Point-of-Care Hemostasis Monitoring
Bleeding Events Before vs After Lowering Departmental Platelet Transfusion Trigger
Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial
Obsidio™ Conformable Embolic Registry
SIMPLAAFY Clinical Trial
Storytelling for Reducing Gap in Anticoagulation Use in African Americans With Atrial Fibrillation
Multi-Omics-Based Novel Thrombosis and Bleeding Markers and Risk Model for CHD
CHAMPION-AF Clinical Trial
Low Tidal MEChanical Ventilation Against NO Ventilation During Cardiopulmonary Bypass Heart Surgery
PK, Safety Study of 90-Day Use of Vaginal Rings Containing Dapivirine and Levonorgestrel
Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure
Aspirin to Target Arterial Events in Chronic Kidney Disease
The Effects of Intraoperative Tranexamic Acid on Perioperative Bleeding In Craniotomies
SWITCH: Apixaban vs Vitamin K in HM3
Concomitant PFA Bsaed PVI Plus LAAC
Factor VIII Inhibitor Bypass Activity (FEIBA) Versus Fresh Frozen Plasma As First Line Therapy For Bleeding After Cardiac Surgery
Comparison of Fibrinogen Concentrate and Cryoprecipitate in Pediatric Cardiac Surgery Patients
Impact of Catheter Ablation on ABC Risk Scores
Safe and Fast Radial Hemostasis Using Synergistic Strategies: SAFE & FAST Trial
Aspirin and Hemocompatibility Events in Chronic Advanced Heart Failure Patients With Assist Device